Neurotensin receptor 1 gene activation by the Tcf/β-catenin pathway is an early event in human colonic adenomas-Reference-Cited by-同舟云学术

Neurotensin receptor 1 gene activation by the Tcf/β-catenin pathway is an early event in human colonic adenomas

Published:2005-11-19 Issue:4 Volume:27 Page:708-716
ISSN:1460-2180
Container-title:Carcinogenesis
language:en
Short-container-title:

Author:

Souazé Frédérique,Viardot-Foucault Véronique,Roullet Nicolas,Toy-Miou-Leong Mireille,Gompel Anne,Bruyneel Erik,Comperat Eva,Faux Maree C,Mareel Marc,Rostène William,Fléjou Jean-François,Gespach Christian,Forgez Patricia

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,General Medicine

Link

http://academic.oup.com/carcin/article-pdf/27/4/708/7090138/bgi269.pdf

Reference47 articles.

1. Heasley,L.E. ( 2001 ) Autocrine and paracrine signaling through neuropeptide receptors in human cancer. Oncogene , 20 , 1563 –1569.

2. Vogt,S., Grosse,R., Schultz,G. and Offermanns,S. ( 2003 ) Receptor-dependent RhoA activation in G12/G13-deficient cells: genetic evidence for an involvement of Gq/G11. J. Biol. Chem ., 278 , 28743 –28749.

3. Jaffe,A.B. and Hall,A. ( 2002 ) Rho GTPases in transformation and metastasis. Adv. Cancer Res. , 84 , 57 –80.

4. Lozano,E., Betson,M. and Braga,V.M. ( 2003 ) Tumor progression: small GTPases and loss of cell–cell adhesion. Bioessays , 25 , 452 –463.

5. Nguyen,Q.D., Faivre,S., Bruyneel,E., Rivat,C., Seto,M., Endo,T., Mareel,M., Emami,S. and Gespach,C. ( 2002 ) RhoA- and RhoD-dependent regulatory switch of Galpha subunit signaling by PAR-1 receptors in cellular invasion. FASEB J. , 16 , 565 –576.

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adding of neurotensin to non-small cell lung cancer cells increases tyrosine phosphorylation of HER3;Peptides;2022-10

2. An Insight into Neuropeptides Inhibitors in the Biology of Colorectal Cancer: Opportunity and Translational Perspectives;Applied Sciences;2022-09-07

3. Neuropeptides in Cancer: Friend and Foe?;Advanced Biology;2022-07

4. The Neurotensinergic System: A Target for Cancer Treatment;Current Medicinal Chemistry;2021-10-27

5. Bombesin, endothelin, neurotensin and pituitary adenylate cyclase activating polypeptide cause tyrosine phosphorylation of receptor tyrosine kinases;Peptides;2021-03